Metraipolis › archive › dc_6949758ecc02
Targeting EZH2-driven cholesterol metabolic vulnerability through Napabucasin suppresses ovarian cancer metastasis — Europe PMC PMID:42373608
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/42373608
- DOI
- 10.1038/s41419-[numero omesso]-9
- License (as archived)
- solo-consultazione
- Archived
- 2026-10-31T08:17:18.224Z
- SHA-256 of the archived text
c9b251ce12e5f1d19c95c2eef1d0de7aa77848a22981265e7a94696b258b7a70- Stable URL of this page
https://metraipolis.com/documento/dc_6949758ecc02
How to cite
Targeting EZH2-driven cholesterol metabolic vulnerability through Napabucasin suppresses ovarian cancer metastasis — Europe PMC PMID:42373608 — Europe PMC (en), https://europepmc.org/article/MED/42373608 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_6949758ecc02 (Metraipolis archive dc_6949758ecc02, sha256 c9b251ce12e5f1d19c95c2eef1d0de7aa77848a22981265e7a94696b258b7a70)
BibTeX
@misc{dc6949758ecc02,
title = {Targeting EZH2-driven cholesterol metabolic vulnerability through Napabucasin suppresses ovarian cancer metastasis — Europe PMC PMID:42373608},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/42373608},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_6949758ecc02; sha256 c9b251ce12e5f1d19c95c2eef1d0de7aa77848a22981265e7a94696b258b7a70},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42373608. Agents can read the archived copy with the MCP tool read_document.